Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sphingosine | 6 | 2024 | 308 | 0.850 |
Why?
|
| Lysophospholipids | 6 | 2024 | 338 | 0.840 |
Why?
|
| Nasal Lavage Fluid | 1 | 2017 | 17 | 0.600 |
Why?
|
| Occupational Exposure | 3 | 2017 | 1807 | 0.550 |
Why?
|
| Isocyanates | 1 | 2013 | 12 | 0.440 |
Why?
|
| Nasal Obstruction | 1 | 2013 | 163 | 0.370 |
Why?
|
| Occupational Diseases | 3 | 2017 | 1458 | 0.350 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 2634 | 0.330 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1890 | 0.310 |
Why?
|
| Respiratory Tract Diseases | 1 | 2013 | 744 | 0.290 |
Why?
|
| Capillary Permeability | 2 | 2022 | 773 | 0.280 |
Why?
|
| Lipocalins | 1 | 2024 | 161 | 0.210 |
Why?
|
| Endothelial Cells | 3 | 2022 | 3591 | 0.210 |
Why?
|
| Proteins | 1 | 2017 | 6011 | 0.210 |
Why?
|
| Apolipoproteins | 1 | 2024 | 328 | 0.190 |
Why?
|
| Receptors, Lysosphingolipid | 2 | 2024 | 123 | 0.190 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 255 | 0.190 |
Why?
|
| Immune System Phenomena | 1 | 2019 | 17 | 0.170 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 506 | 0.170 |
Why?
|
| Receptor Cross-Talk | 1 | 2019 | 118 | 0.160 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2019 | 241 | 0.150 |
Why?
|
| Rhinitis | 2 | 2017 | 754 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13699 | 0.140 |
Why?
|
| Endothelium, Vascular | 2 | 2020 | 4428 | 0.130 |
Why?
|
| Acute-Phase Proteins | 1 | 2017 | 252 | 0.130 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 522 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2019 | 763 | 0.120 |
Why?
|
| Lymphatic Vessels | 1 | 2019 | 356 | 0.120 |
Why?
|
| Skin Tests | 1 | 2017 | 639 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 1231 | 0.120 |
Why?
|
| Hypochondriasis | 1 | 2013 | 93 | 0.100 |
Why?
|
| Fibrosis | 1 | 2019 | 2081 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2019 | 1345 | 0.100 |
Why?
|
| Cardiovascular System | 1 | 2019 | 840 | 0.100 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2006 | 577 | 0.090 |
Why?
|
| Reperfusion Injury | 1 | 2017 | 1036 | 0.090 |
Why?
|
| Inhalation Exposure | 1 | 2013 | 431 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1094 | 0.090 |
Why?
|
| Mice | 7 | 2024 | 82074 | 0.090 |
Why?
|
| Anxiety Disorders | 2 | 2013 | 2748 | 0.080 |
Why?
|
| Homeostasis | 1 | 2019 | 3348 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3473 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2260 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14485 | 0.070 |
Why?
|
| Cell Movement | 1 | 2019 | 5216 | 0.070 |
Why?
|
| Lipoproteins, HDL | 2 | 2024 | 682 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2013 | 1129 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4413 | 0.070 |
Why?
|
| Animals | 8 | 2024 | 169408 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10486 | 0.060 |
Why?
|
| Paroxetine | 1 | 2024 | 181 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 17174 | 0.050 |
Why?
|
| Cytokines | 1 | 2017 | 7453 | 0.050 |
Why?
|
| Asthma | 3 | 2006 | 6293 | 0.050 |
Why?
|
| Endothelium | 1 | 2024 | 768 | 0.050 |
Why?
|
| Bleomycin | 1 | 2022 | 493 | 0.040 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2019 | 78 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2019 | 23652 | 0.040 |
Why?
|
| Humans | 13 | 2024 | 768887 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 9564 | 0.040 |
Why?
|
| Hypertension | 1 | 2017 | 8615 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2019 | 692 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2006 | 2701 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2022 | 1161 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 2475 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2022 | 2674 | 0.030 |
Why?
|
| Receptors, Fc | 1 | 2017 | 538 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2006 | 3726 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15662 | 0.030 |
Why?
|
| Middle Aged | 4 | 2017 | 223740 | 0.030 |
Why?
|
| Adult | 4 | 2017 | 223818 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1494 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 22381 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 1248 | 0.020 |
Why?
|
| Male | 5 | 2017 | 365249 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 2542 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4291 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 9264 | 0.020 |
Why?
|
| Canada | 2 | 2006 | 2129 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 1695 | 0.020 |
Why?
|
| Quebec | 1 | 2006 | 139 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 9344 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15603 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2006 | 355 | 0.010 |
Why?
|
| Quality of Life | 1 | 2006 | 13510 | 0.010 |
Why?
|
| Inflammation | 1 | 2024 | 10869 | 0.010 |
Why?
|
| Phenotype | 1 | 2022 | 16735 | 0.010 |
Why?
|
| Lung | 1 | 2022 | 10097 | 0.010 |
Why?
|
| Workers' Compensation | 1 | 2003 | 150 | 0.010 |
Why?
|
| Female | 3 | 2017 | 397464 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13317 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 13020 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15875 | 0.010 |
Why?
|
| Allergens | 1 | 2003 | 1444 | 0.010 |
Why?
|
| Patient Selection | 1 | 2006 | 4265 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10778 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 5544 | 0.010 |
Why?
|
| Comorbidity | 1 | 2006 | 10591 | 0.010 |
Why?
|
| Air Pollutants | 1 | 2003 | 2905 | 0.000 |
Why?
|
| Incidence | 1 | 2006 | 21545 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 26384 | 0.000 |
Why?
|
| Risk Factors | 1 | 2006 | 74971 | 0.000 |
Why?
|
| United States | 1 | 2003 | 73180 | 0.000 |
Why?
|
| Aged | 1 | 2006 | 171790 | 0.000 |
Why?
|
Concepts
(104)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_